Annual report 2018

Galenica annual report 2018 | 3 Patient protection: actively combating counterfeit drugs The safety and health of patients take top priority at Galenica. The company is therefore actively involved in protection against drug counterfeiting and is progressively implement­ ing the European Commission’s Falsified Medicines Directive. 32 Information regarding the Sustainability Report As definitive sustainability data are not yet available during the drafting of the annual report, the Sustainability Report is published in the second quarter of the following year. Accordingly, it does not form part of the annual report and is published on the website at the appropriate time: www.galenica.com . There is, however, one feature on a selected sustain­ ability topic in this annual report 2018. Content Annual Report 2018 4 Key figures 2018 6 Foreword 10 What we offer 12 Ambition and Strategy 14 Health & Beauty Segment 16 Retail Business sector 20 Products & Brands Business sector 24 Services Segment 26 Services Business sector 30 Political environment 32 Sustainability coverage Patient protection: actively combating counterfeit drugs 36 Human Resources 46 Illustration: the pharmacy online 48 Corporate Governance 66 Remuneration Report 80 Financial statements 2018 80 Galenica Group 131 Galenica Ltd. 140 Addresses of companies of the Galenica Group Galenica